Meghan Verena Joyce - 04 Jan 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
04 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 17:34:40 UTC
Previous filing
06 Dec 2022
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +67 +6.3% $0.000000 1,128 04 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -67 -3.2% $0.000000 2,057 04 Jan 2023 COMMON STOCK 67 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.